6-K ·Filed Jul 24, 2026

QTEX

QTREX Quantum Ltd.
NEUTRAL
Impact 5/10
Horizonweeks Processed2mo ago SEC0001185185-26-003120
Notable filing: 6-K
Actionable Insight • Neutral

The most significant item is Proposal 11, which would entrench the board via a staggered structure and enable a poison pill. Passage would make a hostile takeover significantly more difficult. Monitor the shareholder vote outcome on August 28, 2026; if Proposal 11 passes, the stock's vulnerability to activist or takeover approaches is materially reduced. The tripling of authorized shares (Proposal 10) also provides a potential dilutive overhang for future financings.

DirectionNeutral
Confidencehigh
Horizonweeks
Latest settled — T+20d
QTEX ▼ -8.77% at T+20d
NEUTRAL call ✗ call lost -8.77% · α vs SPY -12.07% · entry $0.9497 → $0.8664
Next anchor: T+60d in 16d
Latest observation: T+49 -30.80% FF3 residual α
Entry anchored
Jul 24, 03:58 PM ET
via exchange tick
T+1d
-8.09%
call -8.09% · α -8.33%
$0.8729
settled 2mo ago
T+5d
-5.23%
call -5.23% · α -6.31%
$0.9000
settled 2mo ago
T+20d
-8.77%
call -8.77% · α -12.07%
$0.8664
settled 6w ago
T+60d
—
call — · α —
—
in 16d

Price Chart

Loading chart...

Executive Summary

QTREX Quantum Ltd. filed a 6-K furnishing its proxy statement for the Annual and Extraordinary General Meeting on August 28, 2026. The meeting agenda includes routine items (auditor re-appointment, director elections, compensation policy renewal) and a significant governance overhaul: Proposal 11 seeks to adopt a staggered board, a shareholder rights plan, and an exclusive forum clause, all requiring a 70% supermajority vote. The filing also proposes a tripling of authorized shares from 100M to 300M, providing flexibility for future capital needs. This is a governance-focused filing with no financial results, making it neutral in sentiment but notable for the anti-takeover provisions.

Key Facts

  • Meeting scheduled for August 28, 2026, to vote on 11 proposals.
  • Proposal 11 seeks to implement a staggered board (3 classes, 3-year terms), a shareholder rights plan, and an exclusive forum clause.
  • Proposal 10 seeks to increase authorized share capital from 100M to 300M ordinary shares.
  • Proposal 3 seeks approval of an updated compensation policy for a 3-year term, including provisions for equity in lieu of salary.
  • Proposals 4-9 seek approval of increased fees and RSU grants for the CEO, Chairman, and non-executive directors.
  • Proposal 11 requires a 70% supermajority vote of shares present and voting to pass.
  • The filing is a proxy solicitation for an annual meeting; no financial results are reported.

Financial Impact

No financial results reported. The filing proposes increasing authorized share capital from 100M to 300M shares and approving executive compensation changes, including RSU grants valued at approximately $527,589 each for the CEO and Chairman.

dilutionauthorized sharesexecutive compensation

Risk Factors

  • Passage of Proposal 11 (staggered board and rights plan) would entrench management and reduce the likelihood of a successful hostile takeover.
  • Approval of Proposal 10 (increase in authorized shares) creates potential for future dilutive equity issuances without further shareholder vote.
  • The proposed RSU grants to executives and directors will result in future dilution as shares vest.
  • The updated compensation policy allows for exchanging accrued salary for equity at a discount of up to 50%, which could be dilutive.

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
86% bullish (7 analysts)

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001185185-26-003120
Document: qtrex6k072326.htm0001185185-26-003120
Document: 0001185185-26-003120-index-headers.html0001185185-26-003120
Document: 0001185185-26-003120-index.html0001185185-26-003120
Document: 0001185185-26-003120.txt0001185185-26-003120
19 reports for QTEX
Performance horizon
67% Hit rate 4 of 6 directional calls best @ T+60▲ +53.16%Jun 17, 2026
Filters
Rows
Reports for QTEX — sortable, filterable
TypeNow
Sep 2, 2026
4w ago
6-K
BULLISH ★ 7/10
$0.8160 $0.6820▼ −16.42%▼ −16.34%$1.10 (+34.80%)
Aug 21, 2026
6w ago
424B5
BEARISH ★ 6/10
$0.9155 $0.8564▲ +6.46%▲ +5.93%$1.10 (−20.15%)
Aug 19, 2026
6w ago
6-K
NEUTRAL ★ 4/10
$1.12 $0.8702▼ −22.30%▼ −20.35%$1.10 (−1.79%)
Aug 3, 2026
8w ago
6-K
NEUTRAL ★ 4/10
$1.01 $0.8273▼ −18.09%▼ −19.33%$1.10 (+8.91%)
Jul 31, 2026
9w ago
Press Release
NEUTRAL ★ 4/10
$0.9000 $0.8340▼ −7.33%▼ −10.32%$1.10 (+22.22%)
Jul 24, 2026
10w ago
6-K
NEUTRAL ★ 5/10
$0.9497 $0.8664▼ −8.77%▼ −12.07%$1.10 (+15.83%)
Jul 22, 2026
10w ago
Press Release
MIXED ★ 5/10
$0.9060 $1.12▲ +23.62%▲ +20.72%$1.10 (+21.41%)
Jul 17, 2026
11w ago
6-K
NEUTRAL ★ 2/10
$1.27 $0.9799▼ −22.84%▼ −27.29%$1.10 (−13.39%)
Jul 17, 2026
11w ago
Press Release
NEUTRAL ★ 2/10
$1.27 $0.9799▼ −22.84%▼ −27.29%$1.10 (−13.39%)
Jul 14, 2026
11w ago
6-K
BULLISH ★ 5/10
$1.50 $0.9959▼ −33.61%▼ −36.10%$1.10 (−26.67%)
Showing 10 of 19

US Market Status

Market Closed — Opens Mon (56h 22m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access